EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating microRNAs as potential candidate biomarkers of left ventricular reverse remodeling after myocardial infarction: A pilot study

Roksana Gozdowska iD, Marcin Konopka, Anna Hojka-Osińska, Grzegorz Jas, Katarzyna Czarzasta, Agnieszka Cudnoch-Jędrzejewska, Wojciech Braksator, Dominika Klimczak-Tomaniak iD, Marek Kuch

PLOS One · 2026

DOI: 10.1371/journal.pone.0360414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Roksana Gozdowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hypertension and Internal Diseases, Mazovian Brodnowski Hospital, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Myocardial Infarction, Ventricular Remodeling, Circulating MicroRNA, MicroRNAs. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myocardial infarction (MI) induces cardiac remodeling and lead to heart failure. Some patients experience reverse remodeling, characterized by improved LV function. MicroRNAs (miRNAs) regulate gene expression and play a crucial role in remodeling processes.

Objectives

We aimed to investigate the role of miRNAs in cardiac reverse remodeling after MI and identify candidate miRNAs that could predict better response to cardiac rehabilitation.

Methods

The study enrolled 39 patients following their first MI. For final analysis, 10 patients meeting echocardiographic criteria for LVRR at 8-week follow-up (absolute LVEF increase ≥ 10% or LVESV reduction ≥ 15%) were matched with 10 patients with stable LV status (SLVS). All patients completed a cardiac rehabilitation program. Expression of 375 circulating miRNAs was quantified – those with higher baseline accumulation in the LVRR group were identified as candidate biomarkers and their target genes were analyzed.

Results

Twenty patients (mean age 57 ± 9 years) were analyzed. At baseline, the SLVS group exhibited significantly higher LVEF compared to the LVRR group (53% vs. 44%, p = 0.013). Baseline regional contractility impairment in all LVRR patients was reversed in 70% of them at follow-up. Fourteen miRNAs (-15b-5p, −24-3p, -29c-3p, -99b-5p, −127-3p, -146a-5p, -199a-3p, −361-5p, −502-5p, −625-5p, -376c-3p, -18b-5p, −342-5p, and −429) were identified as candidate LVRR biomarkers. Enrichment analysis linked their targets to PI3K-Akt, MAPK, FoxO, and HIF-1 pathways.

Conclusions

This study identifies 14 candidate miRNAs as LVRR biomarkers post-MI. These findings highlight the biological relevance of non-coding RNA and support the need for further research and validation in large, non-pooled cohorts. Unstructured abstract Myocardial infarction triggers adverse cardiac remodeling, though some patients achieve left ventricular reverse remodeling (LVRR), marked by functional and structural recovery. This pilot study investigated 39 patients to identify circulating microRNAs (miRNAs) that predict positive responses to cardiac rehabilitation. Comparing 10 LVRR responders against 10 stable patients, we quantified 375 miRNAs via RT-qPCR. At baseline, the stable group had higher ejection fractions (53% vs. 44%, p = 0.013), but 70% of LVRR patients reversed regional contractility impairment by the 8-week follow-up. We identified 14 potential biomarkers, including novel candidates (miR-502-5p, miR-376c-3p, and miR-18b-5p), whose target genes enrich pathways like PI3K-Akt, MAPK, and FoxO. These findings bridge the gap between preclinical data and clinical settings, highlighting the therapeutic potential of non-coding RNAs in cardiac reverse remodeling and necessitating further validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionVentricular RemodelingCirculating MicroRNAMicroRNAsHumansPilot ProjectsBiomarkersFemaleMiddle AgedMaleAgedEchocardiographyVentricular Function, Left

Substanzen

BiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Cardiology, Hypertension and Internal Diseases, Mazovian Brodnowski Hospital, Medical University of Warsaw, Warsaw, Poland.
  • Department of Sports Cardiology and Noninvasive Cardiovascular Imaging, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Bioinformatics Facility, International Institute of Molecular and Cell Biology, Poland.
  • Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
  • Department of Heart Failure and Cardiac Rehabilitation, Medical University of Warsaw, Warsaw, Poland.

ORCID-Profile: Roksana Gozdowska, Dominika Klimczak-Tomaniak

Zitieren

APA

Gozdowska, R., Konopka, M., Hojka-Osińska, A., Jas, G., Czarzasta, K., Cudnoch-Jędrzejewska, A., Braksator, W., Klimczak-Tomaniak, D., & Kuch, M. (2026). Circulating microRNAs as potential candidate biomarkers of left ventricular reverse remodeling after myocardial infarction: A pilot study. PLOS One. https://doi.org/10.1371/journal.pone.0360414

Vancouver

Gozdowska R, Konopka M, Hojka-Osińska A, Jas G, Czarzasta K, Cudnoch-Jędrzejewska A, et al. Circulating microRNAs as potential candidate biomarkers of left ventricular reverse remodeling after myocardial infarction: A pilot study. PLOS One. 2026. doi:10.1371/journal.pone.0360414

BibTeX
@article{Gozdowska2026,
  author = {Gozdowska, Roksana and Konopka, Marcin and Hojka-Osińska, Anna and Jas, Grzegorz and Czarzasta, Katarzyna and Cudnoch-Jędrzejewska, Agnieszka and Braksator, Wojciech and Klimczak-Tomaniak, Dominika and Kuch, Marek},
  title = {Circulating microRNAs as potential candidate biomarkers of left ventricular reverse remodeling after myocardial infarction: A pilot study},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0360414}
}
Kostenlos starten →